Medicare AdvantageCoverageMedium impact
MA00.022, Intravenous (IV) Administration of Fluids as a Treatment of a Medical Condition or for the Preparation of Pharmaceuticals, Biologics, and other Substances
Independence Blue Cross·Emergency Medicine, Critical Care, Internal Medicine +5 more·Medical Policy
Effective date
Apr 16, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA00.022 regarding intravenous (IV) administration of fluids for medical treatment and pharmaceutical preparation has been reissued and will take effect on April 16, 2025. This policy update may affect billing procedures and coverage criteria for IV fluid administration services.
Action Required
By April 16, 2025: Billing team must review the complete policy MA00.022 at the provided URL to understand any changes to IV fluid administration billing requirements. Update billing procedures and staff training accordingly for Medicare Advantage plans. Monitor for specific billing code changes or prior authorization requirements once full policy details are available.